These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9361966)

  • 21. Immunologic monitoring of the beneficial effect of one HLA-DR-shared blood transfusion in heart transplant patients.
    Vaessen LM; van Miert PP; van der Mast BJ; Doumaid K; Balk AH; Boog CJ; Weimar W
    J Heart Lung Transplant; 2000 Nov; 19(11):1098-107. PubMed ID: 11077228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretransplant donor-specific and non-specific immune parameters associated with early acute rejection.
    Reinsmoen NL; Cornett KM; Kloehn R; Burnette AD; McHugh L; Flewellen BK; Matas A; Savik K
    Transplantation; 2008 Feb; 85(3):462-70. PubMed ID: 18301338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of HLA-DR matching between living kidney donors and recipients and of pretransplant blood transfusions on graft survival.
    Akiyama N; Sugimoto H; Kusaba R; Takahashi I; Ohsawa N; Inou T; Samaru Y
    Jpn J Exp Med; 1981 Feb; 51(1):37-43. PubMed ID: 6458714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The putative mechanism of the immunomodulating effect of HLA-DR shared allogeneic blood transfusions on the alloimmune response.
    Waanders MM; Roelen DL; Brand A; Claas FH
    Transfus Med Rev; 2005 Oct; 19(4):281-7. PubMed ID: 16214017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microchimerism and rejection in clinical transplantation.
    Elwood ET; Larsen CP; Maurer DH; Routenberg KL; Neylan JF; Whelchel JD; O'Brien DP; Pearson TC
    Lancet; 1997 May; 349(9062):1358-60. PubMed ID: 9149698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of mismatches for HLA-DR with incidence of posttransplant hip fracture in kidney transplant recipients.
    Opelz G; Döhler B
    Transplantation; 2011 Jan; 91(1):65-9. PubMed ID: 21452411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood transfusion induced changes in cell-mediated lympholysis: to immunize or not to immunize.
    Lagaaij EL; Ruigrok MB; van Rood JJ; Hendriks GF; van der Woude F; Weimar W; van Houwelingen HC; Goulmy E
    J Immunol; 1991 Nov; 147(10):3348-52. PubMed ID: 1940340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The development and specificity of antiidiotypic antibodies in renal transplant recipients receiving single-donor blood transfusions.
    Phelan DL; Rodey GE; Anderson CB
    Transplantation; 1989 Jul; 48(1):57-60. PubMed ID: 2473550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients.
    Najafian N; Salama AD; Fedoseyeva EV; Benichou G; Sayegh MH
    J Am Soc Nephrol; 2002 Jan; 13(1):252-259. PubMed ID: 11752045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-A antigen incompatibility and HLA-B antigen compatibility associated with enhanced kidney allograft survival in blood-transfused patients.
    Bućin D
    Exp Clin Immunogenet; 1986; 3(3):138-44. PubMed ID: 3274633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithymocyte globulin, pretransplant blood transfusion, and tissue typing in cadaver kidney transplantation.
    Cho SI; Bradley JW; Carpenter CB; Cosimi AB; Monaco AP
    Am J Surg; 1983 Apr; 145(4):464-71. PubMed ID: 6340551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pretransplant blood transfusions revisited: a role for CD(4+) regulatory T cells?
    Roelen D; Brand A; Claas FH
    Transplantation; 2004 Jan; 77(1 Suppl):S26-8. PubMed ID: 14726766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The transfusion effect.
    Cecka M; Toyotome A
    Clin Transpl; 1989; ():335-41. PubMed ID: 2487601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies.
    Itabashi Y; Aikawa A; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Arai T; Kawamura T; Hamasaki Y; Sakai K; Shishido S
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):43-49. PubMed ID: 30777522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term evaluation of proliferative donor antigen-specific reactivity in cadaveric kidney transplant recipients.
    Böhmig GA; Säemann MD; Bergmann M; Watschinger B; Regele H; Windhager T; Mühlbacher F; Hörl WH; Zlabinger GJ
    Transpl Int; 2000; 13(3):187-93. PubMed ID: 10935701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kidney transplantation in the northwest region of England--experience of 1,132 transplants in 21 years.
    Dyer PA; Martin S; Mallick NP; Gokal R; Johnson RW
    Clin Transpl; 1989; ():201-13. PubMed ID: 2487567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. UNOS Registry data: effect of transfusions.
    Cicciarelli J
    Clin Transpl; 1990; ():407-16. PubMed ID: 2103162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitization in renal transplantation.
    Zhou YC; Cecka JM
    Clin Transpl; 1991; ():313-23. PubMed ID: 1820127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that the difference in kidney graft survival in DRw6+ and DRw6- recipients may be explained by a blood transfusion policy that is disadvantageous for DRw6+ recipients.
    Lagaaij EL; Persijn GG; Termijtelen A; Hendricks GF; de Lange P; van Rood JJ
    Transplantation; 1987 Dec; 44(6):788-91. PubMed ID: 3321588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kidney graft failure and presensitization against HLA class I and class II antigens.
    Süsal C; Opelz G
    Transplantation; 2002 Apr; 73(8):1269-73. PubMed ID: 11981420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.